for a $1b market potential and these guys will be patented protection for many years before other generics are allowed.
this is exactly the history of Mayne Pharma that repurposed standard Acne drugs into different formulations and even Aspirin into a cardio treatment drug. They are are 850m market cap company but at their peak we're double this and beyond.
There is no reason why it couldn't be a $1++ company if the patents deliver and efficacy proven of their products.
Ann: Top 20 Holders, page-9
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable